Retatrutide, the dual GLP-1 and GIP receptor agonist, is currently unavailable widely available in the UK . While clinical trials are ongoing, official launch dates remain unclear . People interested in https://esmeewiwb429839.mpeblog.com/75172013/uk-retatrutide-a-overview-to-availability-information